Detalhe da pesquisa
1.
Evolution of Metastases in Space and Time under Immune Selection.
Cell
; 175(3): 751-765.e16, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30318143
2.
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.
N Engl J Med
; 369(11): 1023-34, 2013 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24024839
3.
Regorafenib induced severe toxic hepatitis: characterization and discussion.
Liver Int
; 36(11): 1590-1594, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27500989
4.
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Lancet Oncol
; 16(8): 937-48, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26184520
5.
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Lancet
; 381(9863): 303-12, 2013 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23177514
6.
Phenotypic variation of an ALK-positive large-cell neuroendocrine lung carcinoma with carcinoid morphology during treatment with ALK inhibitors.
Histopathology
; 72(4): 707-710, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28888040
7.
Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab.
HPB (Oxford)
; 15(11): 858-64, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23458554
8.
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Ann Oncol
; 26(4): 822-825, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25814651
9.
Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study.
Clin Cancer Res
; 14(18): 5869-76, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18794099
10.
Radical resection of noncolorectal liver metastases: is cure possible?
Hepatogastroenterology
; 61(133): 1374-9, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25436314
11.
Drug Insight: panitumumab, a human EGFR-targeted monoclonal antibody with promising clinical activity in colorectal cancer.
Nat Clin Pract Oncol
; 5(7): 415-25, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18506165
12.
Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
J Natl Cancer Inst
; 110(1)2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28922789
13.
Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer.
Cancer Discov
; 8(4): 428-443, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29431699
14.
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.
N Engl J Med
; 351(4): 337-45, 2004 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-15269313
15.
Prognostic factors for long-term survival in patients with thoracic metastatic disease: a 10-year experience.
Eur J Cardiothorac Surg
; 31(2): 173-80, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17184996
16.
Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).
PLoS One
; 11(3): e0147599, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27032107
17.
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy.
Target Oncol
; 11(3): 383-400, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26706237
18.
Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study).
ESMO Open
; 1(6): e000111, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28848658
19.
Ossification of a rectal tumor: an uncommon finding.
Acta Gastroenterol Belg
; 78(4): 431-5, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26712056
20.
Panitumumab as a radiosensitizing agent in KRAS wild-type locally advanced rectal cancer.
Target Oncol
; 10(3): 375-83, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25304881